Thursday, 7 September 2017

U.S. FDA warns of problems with EpiPen manufacturing plant

(Reuters) - A U.S. regulator this week told Pfizer Inc’s Meridian Medical Technologies division, maker of the EpiPen injector device, that serious component and product failures have been associated with patient deaths and severe illness.


No comments:

Post a Comment